Company intelligence / Profile preview

PHARAMALAGASY

Antananarivo, Analamanga, Madagascar

Ownership: Private
Development stage: Other

Overview

Pharmalagasy is a state-owned pharmaceutical manufacturing company based in Madagascar, established in 2020 to enhance the nation's pharmaceutical independence. The facility is primarily known for the production of CVO Plus, a capsule-form herbal remedy derived from Artemisia annua used for COVID-19 and malaria. In addition to traditional medicine industrialization, the company focuses on the production of essential generic drugs for the domestic market. The manufacturing plant, located in Tanjombato, aims to adhere to international standards to facilitate the export of Malagasy medical products across the African continent.

Therapeutic areas: Infectious Diseases
Modalities: Botanical extractHerbal medicineSmall molecule
Industry: Biotech

Partnerships

IMRA (Institut Malgache de Recherches Appliquées)

Beyond the preview

Go deeper on PHARAMALAGASY.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on PHARAMALAGASY.

Explore the full profile